Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von fchar99 

Edwards Lifesciences Corp. diskutieren

Edwards Lifesciences Corp.

WKN: 936853 / Symbol: EW / Name: Edwards Lifesciences / Aktie / Ausrüstung & Versorgung / Large Cap /

58,61 €
-0,34 %

Edwards Lifesciences Co. (NYSE: EW) was upgraded by analysts at Daiwa Capital Markets from a "neutral" rating to an "outperform" rating.
Ratings data for EW provided by MarketBeat

Einschätzung Buy
Rendite (%) -3,33 %
Kursziel 72,46
Veränderung
Endet am 09.09.25

Edwards Lifesciences Co. (NYSE: EW) had its price target lowered by analysts at Wells Fargo & Company from $90.00 to $80.00. They now have an "overweight" rating on the stock.
Ratings data for EW provided by MarketBeat

Einschätzung Buy
Rendite (%) -1,46 %
Kursziel 72,45
Veränderung
Endet am 09.09.25

Edwards Lifesciences Co. (NYSE: EW) had its price target lowered by analysts at Barclays PLC from $90.00 to $80.00. They now have an "overweight" rating on the stock.
Ratings data for EW provided by MarketBeat

Einschätzung Buy
Rendite (%) -4,23 %
Kursziel 81,52
Veränderung
Endet am 12.09.25

Edwards Lifesciences Co. (NYSE: EW) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $90.00 price target on the stock.
Ratings data for EW provided by MarketBeat

Einschätzung Buy
Rendite (%) -1,00 %
Kursziel 69,65
Veränderung
Endet am 01.10.25

Edwards Lifesciences Co. (NYSE: EW) had its price target lowered by analysts at Citigroup Inc. from $83.00 to $77.00. They now have a "buy" rating on the stock.
Ratings data for EW provided by MarketBeat